Archives

  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • Cy3 Rabbit Anti-Goat IgG (H+L) Antibody Guide

    2026-08-13

    Cy3 Rabbit Anti-Goat IgG (H+L) Antibody: Practical Workflow Guide

    The Cy3 Rabbit Anti-Goat IgG (H+L) Antibody, SKU K1215, is an affinity-purified polyclonal secondary antibody generated in rabbit against goat immunoglobulins. It binds goat IgG heavy and light chains and carries the Cy3 fluorophore, supporting fluorescent readout after a goat primary antibody has bound the target.

    No directly matched paper evidence was supplied for this SKU. Accordingly, the guidance below separates product-dossier specifications from workflow recommendations and does not assign paper-derived performance values, universal working dilutions, or assay outcomes. APExBIO lists the reagent as a liquid supplied at 1 mg/mL in a glycerol-containing PBS buffer.

    What This Product Solves

    Many immunodetection workflows use a goat primary antibody but require a separately labeled reagent for visualization. This Cy3-conjugated secondary antibody supplies that detection layer without requiring direct fluorescent labeling of the primary antibody. Because it recognizes both heavy and light chains of goat IgG, it can be incorporated into validated immunofluorescence, tissue staining, flow, and ELISA formats in which goat IgG is the intended immunoglobulin target.

    Cy3 has an excitation maximum of 552 nm and an emission maximum of 565 nm. These values help the operator select an appropriate laser, excitation source, filter set, or detector channel, but they do not replace instrument-specific spectral validation. The reagent is therefore relevant as a secondary antibody for ICC/IF and IHC, a secondary antibody for flow cytometry, and a secondary antibody for ELISA detection when the reader is configured for fluorescence.

    Its practical value is signal amplification in immunodetection: one goat primary antibody can provide binding sites for labeled secondary antibodies, increasing the detectable fluorescent signal relative to an unlabeled primary alone. The extent of signal improvement depends on antibody affinity, target abundance, sample preparation, background, and instrument sensitivity, so it must be established experimentally.

    Protocol Parameters

    • Assay: ICC/IF, IHC-Fr, IHC-P, flow cytometry, and fluorescence-based ELISA; Value: supplied concentration 1 mg/mL; Applicability: product stock across the listed immunodetection formats; Rationale: use the stock concentration to prepare an assay-specific working dilution rather than assuming the supplied concentration is a staining concentration; Evidence basis: product dossier.
    • Assay: Fluorescence imaging and flow detection; Value: excitation maximum 552 nm and emission maximum 565 nm; Applicability: Cy3-compatible microscopes, cytometers, and fluorescence readers; Rationale: confirm that the instrument channel and optical filters provide adequate coverage around the Cy3 spectral maxima; Evidence basis: product dossier.
    • Assay: Short-term handling; Value: 4°C for up to 2 weeks; Applicability: unopened or working laboratory stock during near-term use; Rationale: maintain the specified refrigerated condition and protect the conjugate from light during storage and handling; Evidence basis: product dossier.
    • Assay: Long-term storage; Value: aliquot at -20°C for up to 12 months; Applicability: retained product stock; Rationale: aliquoting limits repeated freeze-thaw exposure, while light protection helps preserve fluorescence; Evidence basis: product dossier.
    • Assay: All listed immunodetection formats; Value: 23% glycerol, PBS, 1% BSA, and 0.02% sodium azide; Applicability: supplied liquid formulation; Rationale: account for glycerol, protein, and preservative components when assessing compatibility with live-cell work, enzyme reactions, fixation, or downstream sample processing; Evidence basis: product dossier plus workflow recommendation.
    • Assay: Any application; Value: assay-specific dilution and incubation conditions; Applicability: ICC/IF, IHC, flow cytometry, and ELISA optimization; Rationale: the dossier does not specify a universal dilution or incubation time, so optimize against signal, background, sample type, and instrument response; Evidence basis: workflow recommendation.

    Workflow Setup and QC Checklist

    Before staining

    1. Confirm that the primary antibody is raised in goat and is an IgG suitable for the intended assay. Do not select K1215 solely because the target antigen is compatible; the secondary recognizes the immunoglobulin species and chains, not the antigen itself.
    2. Review the sample format and processing history. For ICC/IF, define fixation, permeabilization, and blocking conditions before adding the primary. For IHC-Fr and IHC-P, validate section handling, antigen retrieval, and tissue autofluorescence controls independently.
    3. Verify that the microscope, cytometer, or plate reader has a Cy3-compatible detection channel. Record the selected optical configuration so that changes in filter sets or detector settings do not become an uncontrolled source of variation.
    4. Thaw or mix the reagent gently when required, keep it protected from light, and avoid repeated freeze-thaw cycles. Prepare a working aliquot rather than returning repeatedly handled material to the long-term stock.

    Assay execution

    Apply the goat primary antibody using a validated blocking and washing scheme. After primary incubation, wash sufficiently to remove unbound immunoglobulin, then add K1215 at a dilution determined by a small titration series. Use the same secondary incubation time, wash conditions, and imaging settings across compared samples. For ICC/IF, minimize exposure to intense illumination before image acquisition. For IHC, include a section processed without primary antibody to distinguish secondary-associated background from tissue autofluorescence.

    In flow cytometry, establish single-color and unstained controls, and include compensation or spectral-unmixing controls appropriate to the instrument. If cells are fixed or permeabilized, validate that the treatment does not alter accessibility or increase nonspecific staining. Because the formulation contains sodium azide and the product is not described here as a live-cell reagent, compatibility with viable-cell assays must be established before use.

    For ELISA, use K1215 as a fluorescent detector for a goat IgG-based immunodetection design rather than as a substitute for an enzyme-conjugated reagent. Confirm that the plate reader supports Cy3 excitation and emission, and include blank, no-primary, and known-positive wells. Fluorescent background from the plate, substrate components, or sample matrix should be measured before interpreting weak signal.

    QC checklist

    • Include a known goat IgG positive control to verify secondary binding and instrument response.
    • Run a secondary-only control to measure nonspecific adsorption or sample-associated background.
    • Use a no-primary control in tissue and cell assays.
    • Keep primary species, secondary species, conjugate, lot, dilution, incubation, wash, and acquisition settings in the experiment record.
    • Compare signal-to-background, not signal intensity alone, when selecting the working dilution.

    For a broader assay map, see Cy3 Rabbit Anti-Goat IgG (H+L) Antibody: Technical Applications Guide; it complements this article by organizing the supported ICC/IF, IHC, flow, and ELISA contexts. For stepwise experimental planning, see Cy3 Rabbit Anti-Goat IgG (H+L) Antibody: Technical Workflow Guide; it complements the QC and troubleshooting emphasis here.

    Common Failure Modes and Fixes

    No or weak fluorescence

    First check the host species of the primary antibody. A non-goat primary is outside the demonstrated pairing for this reagent. Next verify the Cy3 optical channel, reagent storage history, and light exposure. If these checks pass, compare several assay-specific secondary dilutions and confirm that fixation, permeabilization, or antigen retrieval has not reduced target accessibility.

    High background

    Common causes include excessive secondary concentration, inadequate blocking, insufficient washing, tissue autofluorescence, or nonspecific adsorption. Reduce the working concentration through titration, strengthen or optimize blocking, extend or improve washing as appropriate for the assay, and compare secondary-only and no-primary controls. For tissue, evaluate an unstained section to measure intrinsic fluorescence.

    Unexpected signal in negative controls

    Signal in a secondary-only control indicates nonspecific secondary binding, sample autofluorescence, or residual binding sites. Confirm that the primary was omitted correctly, inspect the sample without fluorophore, and test a different blocking or washing condition. Do not interpret such signal as evidence of antigen expression.

    Uneven tissue staining

    Patchy IHC or ICC signal can result from inconsistent section thickness, drying, incomplete deparaffinization, uneven retrieval, or poor reagent coverage. Standardize section preparation, keep samples wet during staining, and ensure complete coverage during primary and secondary incubations.

    Broad or poorly resolved flow populations

    Review cell preparation, nonspecific binding, Fc-receptor-associated background, viability, wash quality, and compensation. Use unstained and single-color controls, and separate changes in sample preparation from changes in Cy3 detector settings.

    Scope and Limitations

    K1215 is a secondary reagent for goat IgG detection, not a direct antigen-detection antibody. Its intended pairing is with goat primary antibodies in validated immunodetection workflows. Do not assume reactivity with non-goat immunoglobulins, non-IgG isotypes, immunoglobulin fragments, or unrelated proteins without experimental validation.

    The H+L designation indicates recognition of goat IgG heavy and light chains, but it does not by itself establish performance for every goat antibody format or every sample matrix. Affinity purification is intended to support specificity and low background, but it does not eliminate the need for blocking, washing, and negative controls. The stated 552 nm and 565 nm maxima are spectral reference points rather than a guarantee of equivalent signal on every instrument.

    The supplied buffer contains glycerol, BSA, and sodium azide. Assess compatibility with live cells, enzyme-linked reactions, surface labeling, and any assay sensitive to preservatives or protein additives. The dossier also does not provide a universal dilution, incubation time, lot-specific background value, or directly matched paper result; these variables must be validated in the laboratory.

    Conclusion

    The Cy3 Rabbit Anti-Goat IgG (H+L) Antibody is a practical fluorescent secondary for detecting goat IgG in ICC/IF, frozen and paraffin IHC, flow cytometry, and fluorescence ELISA. Reliable use depends on correct goat-primary pairing, Cy3-compatible detection, controlled storage, assay-specific titration, and explicit negative controls. Treat the product dossier as the basis for specifications and use local QC experiments to establish performance in the chosen sample and workflow.